Corvus Pharmaceuticals, Inc.
CRVS· Nasdaq
Corvus Pharmaceuticals, Inc.
- Last sale
- Oct 2, 2026 · -0.23%
- Market cap
- $917.76M
- 84.12M shares
- Filings
- 581
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $33,719,000 | reported | |
| FY 2024 | 2024-12-31 | $19,385,000 | reported | |
| FY 2023 | 2023-12-31 | $16,526,000 | reported | |
| FY 2021 | 2022-12-31 | $24,468,000 | reported | |
| FY 2020 | 2021-12-31 | $29,115,000 | reported | |
| FY 2019 | 2020-12-31 | $31,830,000 | reported | |
| FY 2018 | 2018-12-31 | $38,586,000 | reported | |
| FY 2017 | 2017-12-31 | $46,305,000 | reported | |
| FY 2016 | 2016-12-31 | $29,356,000 | reported | |
| FY 2015 | 2015-12-31 | $11,352,000 | reported | |
| FY 2014 | 2014-12-31 | $38,000 | reported |
Corvus Pharmaceuticals, Inc. · CIK 1626971 · Engraved from SEC EDGAR
